0001209191-19-022659.txt : 20190402
0001209191-19-022659.hdr.sgml : 20190402
20190402171942
ACCESSION NUMBER: 0001209191-19-022659
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190402
DATE AS OF CHANGE: 20190402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YAO TONY DUNG LING
CENTRAL INDEX KEY: 0001771680
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19726334
MAIL ADDRESS:
STREET 1: C/O PRECISION BIOSCIENCES, INC.
STREET 2: 302 EAST PETTIGREW STREET, SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC
CENTRAL INDEX KEY: 0001357874
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-314-5512
MAIL ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-01
0
0001357874
PRECISION BIOSCIENCES INC
DTIL
0001771680
YAO TONY DUNG LING
C/O PRECISION BIOSCIENCES, INC.
302 E. PETTIGREW STREET, SUITE A-100
DURHAM
NC
27701
1
0
0
0
Common Stock
2019-04-01
4
C
0
4450
A
4450
D
Common Stock
2019-04-01
4
C
0
36946
13.60
A
36946
I
By ArrowMark Life Science Fund, LP
Common Stock
2019-04-01
4
C
0
114570
A
151516
I
By ArrowMark Life Science Fund, LP
Common Stock
2019-04-01
4
C
0
4450
A
4450
I
By THB Iron Rose, LLC Life Science Portfolio
Series B Preferred Stock
2019-04-01
4
C
0
9500
D
Common Stock
4450
0
D
Convertible Promissory Note
13.60
2019-04-01
4
C
0
502466.00
D
Common Stock
36946
0
I
By ArrowMark Life Science Fund, LP
Series B Preferred Stock
2019-04-01
4
C
0
244572
D
Common Stock
114570
0
I
By ArrowMark Life Science Fund, LP
Series B Preferred Stock
2019-04-01
4
C
0
9500
D
Common Stock
4450
0
I
By THB Iron Rose, LLC Life Science Portfolio
The Series B Preferred Stock automatically converted into the common stock of Precision BioSciences, Inc. (the "Issuer") on a 2.134686-to-1 basis (after giving effect to the Issuer's previously completed reverse stock split) upon the closing of the Issuer's initial public offering (the "IPO").
These securities are held of record by the ArrowMark Life Science Fund, LP (the "ArrowMark Fund"). ArrowMark Colorado Holdings LLC ("ArrowMark Colorado") is an investment advisor to the ArrowMark Fund. The reporting person is employed as a portfolio manager for ArrowMark Colorado and has direct voting and dispositive control over the shares held by the ArrowMark Fund. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
These securities are held of record by the THB Iron Rose, LLC Life Science Portfolio (the "THB Fund"). ArrowMark Colorado is an investment advisor to the THB Fund. The reporting person is employed as a portfolio manager for ArrowMark Colorado and has direct voting and dispositive control over the shares held by the THB Fund. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
On March 1, 2019, the ArrowMark Fund acquired a convertible promissory note in the principal amount of $500,000 (the "2019 Note") from the Issuer. Effective upon the closing of the IPO on April 1, 2019, the 2019 Note, including accrued interest, converted into 36,946 shares of the Issuer's common stock at a price per share equal to $13.60, which represented 85% of the price per share in the IPO.
/s/ Abid Ansari, Attorney-in-Fact for Tony Dung-Ling Yao
2019-04-02